The pathogenic potential of these CD4<sup>+</sup>CD28<sup>-</sup> T cells is driven by the coupling of the IL-15/IL-15R signaling pathway and the NKG2D/DAP10 signaling pathway, which may open new avenues for therapeutic intervention to prevent SLE progression. This evidence concerns the gene IL15 and systemic lupus erythematosus.